Polyhydroxy Acids (PHAs): The Mechanism Behind Skincare's Gentlest Exfoliant Class

Polyhydroxy acids occupy an awkward position in the chemical-exfoliant category. They appear in the same conversation as glycolic and lactic acid, they are described in the same paragraph of every dermstore listing, and they are routinely positioned as "AHAs but gentler." That framing is wrong. PHAs are a chemically distinct ingredient class whose larger sugar-derived backbone produces fundamentally different behavior at the skin's surface — not a downgraded version of an AHA, but a separate category whose mechanism, secondary activity, and photoreactivity profile bear closer examination than the existing literature provides. This explainer treats gluconolactone, lactobionic acid, and galactose as the molecules they actually are, anchored in the published dermatology research that brand marketing copy tends to summarize past.

Why the AHA Comparison Misses the Chemistry

Glycolic acid weighs 76 daltons and lactic acid weighs 90 daltons; gluconolactone weighs 178 daltons and lactobionic acid weighs 358 daltons, placing the polyhydroxy class between two and four times the molecular size of the AHAs they are commonly compared against.

That size difference is not a quantitative quibble. The stratum corneum filters topical molecules largely by size and lipid solubility, and small AHAs penetrate the corneal layer rapidly, dropping local pH and triggering corneocyte detachment within minutes of application. PHAs, constrained by their larger profile and their hydroxyl-rich polar surface, advance through the corneum more slowly and to shallower depth. The exfoliation they produce is therefore distributed across a longer time window and across the upper corneal layers rather than concentrated at a single penetration depth. The clinical signature is steady, uniform desquamation without the acute tingle that small AHAs provoke.

The molecular structure also changes how the skin perceives the active. Small AHAs reach free nerve endings in the upper epidermis quickly enough to register as the familiar acid sting; PHAs do not, which is why studies of gluconolactone consistently report subjective tolerance comparable to vehicle controls even at 10 percent concentrations. The acid mantle, the slightly acidic film at the surface of the stratum corneum, is also less disrupted because PHAs buffer at a higher and gentler pH range than glycolic acid formulations. The combined effect is exfoliation that proceeds without the barrier-compromise window that follows AHA use.

Gluconolactone: Exfoliation and Humectant Binding from a Single Molecule

Gluconolactone carries five hydroxyl groups on a six-carbon ring, giving it a hydrogen-bond density that allows the same molecule to function as an exfoliant and as a humectant — a dual activity that single-hydroxyl AHAs cannot replicate from one structural unit.

In aqueous solution, gluconolactone exists in equilibrium with gluconic acid; the open-chain form drives the mild acid effect on corneocyte adhesion, while the lactone ring contributes to the molecule's hydration profile. Each of those hydroxyl groups can hydrogen-bond a water molecule, holding moisture at the corneal surface in much the same way glycerin or panthenol do, but with the added secondary effect of slow chemical exfoliation. A 2004 study in Cutis evaluating 8 percent gluconolactone in subjects with mild-to-moderate photoaging found measurable improvements in skin smoothness, fine lines, and clarity at 12 weeks, with adverse-event rates indistinguishable from vehicle.

The clinical implication is that gluconolactone formulations function as combined humectant exfoliants in a single layer, removing one product from a sensitive-skin routine that would otherwise need an exfoliant and a humectant applied separately. The molecule also accepts formulation alongside niacinamide, peptides, and ceramides without the pH conflict that limits AHA stacking. For routines built around minimal layering and barrier preservation, gluconolactone is the chemical-exfoliant choice that does the most with the fewest auxiliary ingredients.

Lactobionic Acid: Antioxidant Activity and Metal Chelation in Mature Skin

Lactobionic acid combines a galactose unit linked to a gluconic acid backbone, producing a 358-dalton molecule with eight hydroxyl groups and a measurable affinity for divalent cations including calcium, iron, and copper that places it in the rare overlap between exfoliant and antioxidant.

The cation-chelating behavior is mechanistically meaningful for mature skin. Matrix metalloproteinases, the enzymes responsible for collagen and elastin degradation in photoaged dermis, require zinc and calcium as catalytic cofactors; lactobionic acid sequesters these ions at the surface and reduces the free pool available for enzymatic activity. A 2006 study in the Journal of Cosmetic Dermatology evaluating 8 percent lactobionic acid documented improvements in fine lines, skin firmness, and clarity at 12 weeks alongside antioxidant biomarker changes, with the authors specifically noting the molecule's metal-chelating role as a contributor to the effect.

Lactobionic acid also has an established role in post-procedure recovery. Its high water-binding capacity, slow penetration, and freedom from acid sting have made it the chemical exfoliant most often included in barrier-supportive formulations applied after laser resurfacing, microneedling, or chemical peels. The molecule fits a clinical use case where conventional AHAs are contraindicated and where the skin needs both gentle keratinocyte turnover support and protection from oxidative load during re-epithelialization. For mature skin and for compromised-barrier states, lactobionic acid is the PHA that earns its place on the ingredient deck.

Galactose, Photoreactivity, and What PHAs Don't Do

Galactose, the third PHA in the commercial category, appears less frequently in standalone formulations and is most often included in combination with lactobionic acid; in published dermatologic literature, its activity profile mirrors lactobionic acid's water binding without the same metal-chelating breadth.

The more consequential point about the PHA class is the photoreactivity question. Glycolic and lactic acid use comes with a published increase in UV-induced erythema and a recommendation to pair daytime application with diligent SPF; PHAs do not. A 2013 review in the Journal of Drugs in Dermatology and subsequent clinical evaluations have not documented increased photosensitization with PHA use, and lactobionic acid's antioxidant activity may modestly reduce photo-oxidative load rather than amplify it. This is not an invitation to skip sunscreen — daily broad-spectrum SPF remains a non-negotiable foundation for any active-ingredient routine — but it does change the seasonal and post-procedure positioning of the class. PHAs can be used in summer, used the morning of an outdoor event, or used during the recovery phase of a treatment without the photoreactive caution that limits AHA use in those contexts.

What PHAs do not do is replicate the resurfacing depth of a 10 percent glycolic acid serum. Their gentler action is also a slower one, and someone seeking visible texture change in two weeks will be disappointed by an 8 percent gluconolactone serum that produces the same change at twelve weeks. The trade is real and worth naming: PHAs offer durability, tolerance, and barrier compatibility at the cost of speed. For sensitive, reactive, mature, or post-procedure skin, that trade is the right one. For an experienced acid user with intact barrier function and a goal of accelerated cell turnover, an AHA remains the appropriate tool. Treating PHAs as a chemical class with its own indications, rather than as an undertuned AHA, is what allows that distinction to do useful work in an ingredient-led routine.

How to Read a PHA Label and Build It Into a Routine

Functional concentration is the first thing to verify. Below 4 percent, gluconolactone and lactobionic acid behave more as humectants than as exfoliants — useful, but not equivalent to AHA-grade resurfacing. Brands that disclose concentration on the label make this visible; brands that bury PHAs in the lower third of an ingredient deck typically do not deliver an exfoliating dose. Look for concentration on the front label or in technical product documentation.

pH compatibility extends the formulation envelope significantly. PHAs operate well at pH 4.0 to 5.5, which overlaps with the acid mantle's natural range and with the formulation pH of niacinamide, peptides, retinaldehyde, and most ceramide moisturizers. They can be layered under or over these actives without the stacking conflicts that limit glycolic acid pairing. The exception is L-ascorbic acid at pH 3.5 or below — the formulations co-exist on the skin without instability, but the strong acid pH of the vitamin C will dominate the surface chemistry and effectively neutralize the PHA's milder action during the overlap window.

For reactive, rosacea-prone, or mature skin, a single nightly application of an 8 to 10 percent gluconolactone or lactobionic acid serum, applied to clean skin and followed by a ceramide moisturizer, is the routine that the published literature most consistently supports. Expect texture and clarity improvements at four to six weeks and fine-line and firmness changes at twelve. Use of an AHA can be reintroduced once tolerance is established, or kept off the routine entirely if PHA results are sufficient. The point of the PHA class is not to mimic AHAs at lower potency. It is to deliver a different mode of chemical exfoliation, with secondary humectant and antioxidant activity, in skin that needs the alternative — and that alternative deserves to be evaluated on its own chemistry rather than as a fallback.